Remove Innovation Remove Kaplan Remove Operations Remove Training
article thumbnail

Performance Measurement

Strategy Driven

Operating-cost productivity metrics might include the component costs for building an automobile or delivering a package, the rates of rework, and so forth. Pharmaceutical companies have long needed deep scientific-innovation leadership capabilities but relatively few general managers.

ROIC 62
article thumbnail

Don't Wait for Change

Harvard Business Review

As one of his clients said to him, "A train wreck is coming at us.". The main criteria were that the speakers came from outside the industry, and would be able to tell stories (sort of like TED-talks) about how other companies went about innovation and reinvention. But the experience seems to have made him even more committed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Strong Patient-Provider Relationships Drive Healthier Outcomes

Harvard Business Review

“The proper goal for any health care delivery system is to improve the value delivered to patients … To properly manage value, both outcomes and cost must be measured at the patient level,” Harvard’s Robert Kaplan and Michael Porter tell us. But, why do we only define patient value by outcomes and cost?

article thumbnail

Reflecting on David Garvin’s Imprint on Management

Harvard Business Review

Kaplan’s balanced scorecard or Clayton Christensen’s disruptive innovation. Garvin stresses the importance of rigorous experiments (years before experimentation became the rallying cry for a new generation of innovators); thoughtful problem definition; and smart, well-designed metrics.